As preparations for the London Biotechnology Show 2026 continue to gain momentum, Early Bird registrations are now entering their final days. With just a few days remaining, this is the last opportunity to secure delegate access at reduced rates.
Interest from the global biotechnology community remains strong, and registrations are steadily progressing. If attending the show is part of your 2026 plan, now is the moment to confirm your participation before Early Bird pricing expires on 20 February. The event takes place on 9-10 June, 2026 at Excel London.
The London Biotech Show 2026 is Europe’s leading platform for the biotechnology industry, showcasing the full spectrum of red biotech including biopharmaceuticals, therapeutics, gene and cell therapy, regenerative medicine, diagnostics, precision medicine, vaccines, clinical trials, and biomanufacturing.
The event will bring together biotech companies, pharmaceutical leaders, medtech innovators, investors, researchers, policymakers, and solution providers from across the globe to exchange knowledge, forge partnerships, and accelerate innovation.
Through its world-class exhibition, high-level conference, and the Global Biotech Awards, the show enables attendees to explore cutting-edge technologies, secure investments, expand into new markets, and drive the next wave of breakthroughs in healthcare and life sciences.
Early bird prices are reduced by 40%, to £357 for a single ticket, and by 50% to £297 for groups (buying two or more tickets).
Click here to register - https://londonbiotechshow.com/register?t=delegate